Mark Coleman - 15 Sep 2023 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
15 Sep 2023
Net transactions value
-$2,184,002
Form type
4
Filing time
15 Sep 2023, 18:30:32 UTC
Previous filing
06 Jun 2023
Next filing
29 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $40,429 +11,016 +44% $3.67* 36,113 15 Sep 2023 Direct F1, F2
transaction AXSM Common Stock Sale $828,241 -11,016 -31% $75.19 25,097 15 Sep 2023 Direct F2, F3
transaction AXSM Common Stock Sale $1,396,189 -18,572 -4.4% $75.18 403,856 15 Sep 2023 See Footnote F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -11,016 -100% $0.000000* 0 15 Sep 2023 Common Stock 11,016 $3.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options.
F2 Such transaction was pursuant to a pre-approved 10b5-1 plan.
F3 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F4 Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.